Abstract
Regulatory T cells (Tregs) that suppress the activation of immune effector cells limit immunopathology and are fast emerging as therapeutic targets for autoimmune and cancer disease. Tools enabling Treg in vitro-induction, expansion, and characterization and manipulation will help future clinical developments. In this chapter, we describe in detail how to use bacterial superantigens to induce human Tregs efficiently from peripheral blood mononuclear cells. How to assess human Treg phenotype and suppressive capacity are also described. Technical details, variations, and alternative experimental conditions are provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sakaguchi S (2011) Regulatory T cells: history and perspective. Methods Mol Biol 707:3–17. doi:10.1007/978-1-61737-979-6_1
Schmitt EG, Williams CB (2013) Generation and function of induced regulatory T cells. Front Immunol 4:152. doi:10.3389/fimmu.2013.00152
Gratz IK, Campbell DJ (2014) Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol 5:333. doi:10.3389/fimmu.2014.00333
Duhen T, Duhen R, Lanzavecchia A, Sallusto F, Campbell DJ (2012) Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119:4430–4440. doi:10.1182/blood-2011-11-392324
Schmetterer KG, Neunkirchner A, Pickl WF (2012) Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J 26:2253–2276. doi:10.1096/fj.11-193672
Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457–462. doi:10.1038/ni1455
Lin W, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, Chatila TA (2007) Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8:359–368. doi:10.1038/ni1445
Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y, Osaki M, Tanaka Y, Yamashita R, Nakano N, Huehn J, Fehling HJ, Sparwasser T, Nakai K, Sakaguchi S (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37:785–799. doi:10.1016/j.immuni.2012.09.010
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184:3433–3441. doi:10.4049/jimmunol.0904028
Weiss JM, Bilate AM, Gobert M, Ding Y, de Lafaille MA C, Parkhurst CN, Xiong H, Dolpady J, Frey AB, Ruocco MG, Yang Y, Floess S, Huehn J, Oh S, Li MO, Niec RE, Rudensky AY, Dustin ML, Littman DR, Lafaille JJ (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209:1723–1742, S1721. doi:10.1084/jem.20120914
Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, Anthony BA, Sverdrup FM, Head R, Kuster DJ, Ruminski P, Weiss D, Von Schack D, Bluestone JA (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209:1713–1722, S1711–1719. doi:10.1084/jem.20120822
Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, Zheng SG (2013) Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. Int J Clin Exp Pathol 6:116–123
Daniel C, Ploegh H, von Boehmer H (2011) Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol Biol 707:73–185. doi:10.1007/978-1-61737-979-6_11
Fantini MC, Dominitzki S, Rizzo A, Neurath MF, Becker C (2007) In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat Protoc 2:1789–1794. doi:10.1038/nprot.2007.258
Nouze C, Pasquet L, van Meerwijk JP (2011) In vitro expansion of alloantigen-specific regulatory T cells and their use in prevention of allograft rejection. Methods Mol Biol 707:187–196. doi:10.1007/978-1-61737-979-6_12
Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM (2011) IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. J Immunol 186:6329–6337. doi:10.4049/jimmunol.1100061
Taylor AL, Llewelyn MJ (2010) Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype. J Immunol 185:6591–6598. doi:10.4049/jimmunol.1002416
Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM (2006) The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength. Int Immunol 18:1433–1441. doi:10.1093/intimm/dxl076
Taylor AL, Cross EL, Llewelyn MJ (2012) Induction of contact-dependent CD8(+) regulatory T cells through stimulation with staphylococcal and streptococcal superantigens. Immunology 135:158–167. doi:10.1111/j.1365-2567.2011.03529.x
Fessler J, Felber A, Duftner C, Dejaco C (2013) Therapeutic potential of regulatory T cells in autoimmune disorders. BioDrugs 27:281–291. doi:10.1007/s40259-013-0026-5
Caserta S, Borger JG, Zamoyska R (2012) Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens. Crit Rev Immunol 32:97–126
Proft T, Webb PD, Handley V, Fraser JD (2003) Two novel superantigens found in both group A and group C Streptococcus. Infect Immun 71:1361–1369
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Caserta, S., Taylor, A.L., Terrazzini, N., Llewelyn, M.J. (2016). Induction of Human Regulatory T Cells with Bacterial Superantigens. In: Brosnahan, A. (eds) Superantigens. Methods in Molecular Biology, vol 1396. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3344-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3344-0_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3342-6
Online ISBN: 978-1-4939-3344-0
eBook Packages: Springer Protocols